Chiu A T, Carini D J, Johnson A L, McCall D E, Price W A, Thoolen M J, Wong P C, Taber R I, Timmermans P B
Medical Products Department, E.I. du Pont de Nemours & Company, Inc., Wilmington, DE 19898.
Eur J Pharmacol. 1988 Nov 15;157(1):13-21. doi: 10.1016/0014-2999(88)90465-7.
2-Butyl-4-chloro-1-(2-nitrobenzyl)imidazole-5-acetic acid, sodium salt (S-8308), inhibited the specific binding of labeled angiotensin II (AII) to its receptor sites in rat adrenal cortical microsomes and in cultured aortic smooth muscle cells with IC50S of 15 and 4.5 microM, respectively. In the presence of S-8308 (15 microM) the dissociation constant for AII was increased 2-fold and the total number of binding sites was unaltered. In a concentration-dependent manner S-8308 blocked the 45Ca2+ influx induced by AII (3 X 10(-8) M) in rat aortic rings (IC50 7 microM) and the contractile response in rabbit aorta was competitively inhibited (pA2 = 5.74). This agent was highly specific for AII: it showed no affinity for alpha 1-adrenoceptors or Ca2+ channels and in addition, it did not alter the contractile responses to norepinephrine (10(-7) M) or KCl (55 mM). In conscious renal artery-ligated rats, S-8308 (30 mg/kg i.v.) elicited a rapid decrease of mean arterial pressure with a duration of about 30 min. The results demonstrate that S-8308 is a weak, but specific and competitive, non-peptide antagonist of AII exerting its inhibitory action at the receptor level.
2-丁基-4-氯-1-(2-硝基苄基)咪唑-5-乙酸钠盐(S-8308)抑制标记的血管紧张素II(AII)与大鼠肾上腺皮质微粒体和培养的主动脉平滑肌细胞中其受体位点的特异性结合,IC50分别为15和4.5微摩尔。在S-8308(15微摩尔)存在下,AII的解离常数增加2倍,结合位点总数未改变。S-8308以浓度依赖的方式阻断AII(3×10(-8)M)诱导的大鼠主动脉环中45Ca2+内流(IC50 7微摩尔),并竞争性抑制兔主动脉的收缩反应(pA2 = 5.74)。该药物对AII具有高度特异性:它对α1-肾上腺素能受体或Ca2+通道无亲和力,此外,它不改变对去甲肾上腺素(10(-7)M)或KCl(55 mM)的收缩反应。在清醒的肾动脉结扎大鼠中,S-8308(30毫克/千克静脉注射)引起平均动脉压迅速下降,持续时间约30分钟。结果表明,S-8308是一种弱的、但特异性和竞争性的非肽类AII拮抗剂,在受体水平发挥其抑制作用。